Article & News

Drug development rarely progresses in a straight line. A promising compound can still raise questions about tolerability, exposure, target-organ effects, or biological response before formal

Selecting an external toxicology partner is not simply a matter of comparing study prices or available animal models. The more important question is whether the

Drug development can become significantly more expensive when safety questions remain unresolved until later preclinical stages. A candidate may show promising efficacy while its tolerability